Volatiles from Subtropical Convolvulaceae That Interfere with Bacterial Cell-to-Cell Communication as Potential Antipathogenic Drugs by Luciardi, María Constanza et al.
Research Article
Volatiles from Subtropical Convolvulaceae That
Interfere with Bacterial Cell-to-Cell Communication as
Potential Antipathogenic Drugs
María C. Luciardi,1 María V. Pérez Hernández,1 Nora Muruaga,2 Alicia Bardón,1,3
Mario E. Arena,1,3 and Elena Cartagena1
1 Instituto de Quı´mica Orga´nica, Facultad de Bioquı´mica, Quı´mica y Farmacia, Universidad Nacional de Tucuma´n,
Ayacucho 471, 4000 Tucuma´n, Argentina
2Fundacio´n Miguel Lillo, Miguel Lillo 251, 4000 Tucuma´n, Argentina
3INQUINOA-CONICET, Ayacucho 471, 4000 Tucuma´n, Argentina
Correspondence should be addressed to Elena Cartagena; ecartagena@fbqf.unt.edu.ar
Received 21 March 2016; Revised 22 April 2016; Accepted 27 April 2016
Academic Editor: Daniela Rigano
Copyright © 2016 Mar´ıa C. Luciardi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Increasing chronic bacterial infections create an urgent need for new antimicrobial agents or strategies for their control. Targeting
virulence is one of the alternative approaches to find new medicines to treat persistent infections due to bacteria with biofilm-
phenotype which are more resistant to antibiotics than their planktonic counterparts having an extreme capacity for evading
the host defences. A bioguided study of sixteen extracts from flowers and leaves of four subtropical Convolvulaceae species
provided evidence of the occurrence of antipathogenic natural products active against Gram positive and negative bacteria.
Particularly, volatile metabolites from Merremia dissecta creeper, a food and medicinal plant, were able to interfere with the
Pseudomonas aeruginosa quorum sensing system by a strong decrease of N-acyl homoserine lactone (AHL) biosynthesis (63–
75%), which attenuated the virulence factor expression like biofilm (55%) and elastase activity (up to 27%), key factors that
enable the colonization and dissemination of the infection in the host. Control of the P. aeruginosa biofilm and the QS process
by phytochemicals, such as (+) spathulenol, isolated from a bioactive extract ofM. dissecta leaves would be a good strategy for the
development of new and effective antipathogenic drugs.
1. Introduction
Microbes like bacteria can coordinate gene expression as a
community through the secretion and detection of signalling
molecules so that its members can simultaneously express
specific behaviors. This mechanism of regulation, called
quorum sensing (QS), seems to be a key trait for adaptation
to specific environments and has been shown to regulate
a variety of important phenotypes in the production of
virulence factors like biofilm and proteolytic enzymes, crucial
factors that enable colonization and dissemination of the
infection in the host. Persistent and chronic bacterial infec-
tions have been directly linked to the presence of microbial
biofilms. Microbial biofilms are sessile communities of one
or more microorganisms that reside within a self-produced
extracellular matrix. These cellular aggregates can form on
living and nonliving surfaces, soluble and insolublematerials,
are fairly ubiquitous in natural ecosystems, and have serious
implications to human health. The inherent characteristic
of microbial biofilms is a remarkable tolerance to treatment
with antibiotics traditionally effective against planktonic (free
floating) bacteria [1–4].
Biofilm infections, such as pneumonia in cystic fibrosis
patients, chronic wounds, chronic otitis media, and implant
and catheter associated infections, affect millions of people
in the developed world each year and many deaths occur as a
consequence [5].
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There is evidence that bacterial QS process is involved in
cross-kingdom signalling with eukaryotic organisms, mainly
plants, that are capable of producing compounds that can
interfere with QS systems in bacteria by inhibiting QS
signal biosynthesis, which leads to attenuation of virulence
factor expression [6]. Our investigations take inspiration
from nature’s models and attempts to design solutions to the
problem of microbial biofilms [7–11].
Medicinal plants have become part of complementary
medicine worldwide, because of their potential health ben-
efits. Various plant extract has great potential against infec-
tious agents and can be used for therapeutic purposes [12].
Convolvulaceae is a large family comprising about 58 gen-
era and 1650 species of herbs, climbers, or shrubs distributed
in tropical and subtropical regions [13]. The greatest species
diversity occurs in the Americas and Africa. The family can
be recognized by their funnel-shaped radially symmetrical
corollas. The leaves and tuberous roots of some species are
used as foodstuffs, and the seeds are exploited for theirmedic-
inal value as purgatives. Some species contain ergoline alka-
loids that are likely responsible for the use of these species as
ingredients in psychedelic drugs.The presence of ergolines in
some species of this family is due to infection by fungi related
to the ergot fungi of the genus Claviceps. The morning glory
family is a rich source of bioactive compounds such as polyke-
tides, terpenoids, steroids, flavonoids, coumarins, alkaloids,
cyanogenic glycosides, and other compounds [14–16].
Several antibacterial activity studies of Convolvulaceae
species and only a few about antibiofilms effects were previ-
ously published [17–22].Therefore, this investigation presents
a bioguided study of Ipomoea cairica, I. nil, I. purpurea, and
Merremia dissecta that led to the discovery of plant volatiles
that interfere with thePseudomonas aeruginosaQS system, by
declining of the QS signal production which attenuates viru-
lence factor expression like biofilms and elastase B activity. In
vitro antibiofilm effects against Staphylococcus aureus are also
reported for the first time in this paper.
2. Materials and Methods
2.1. Collection and Identification of Plant Materials. Leaves
and flowers of Ipomoea cairica (L.) Sweet, I. nil (L.) Roth,
I. purpurea (L.) Roth, and Merremia dissecta (Jacq.) Hal-
lier f. (Convolvulaceae) were collected during the flower-
ing stage in March, road to Villa Nougue´s (26∘51󸀠28.08󸀠󸀠S,
65∘22󸀠32.16󸀠󸀠W), Tucuma´n province, Argentina. Their iden-
tities were confirmed by Dr. Nora Muruaga and voucher
specimens (LIL 610.873, 610.871, 610.870, and 610.872, resp.)
were deposited at the Herbarium of Fundacio´n Miguel Lillo,
Tucuma´n, Argentina.
2.2. Preparation of Plant Extracts. The fresh plant material
(leaves or flowers, 25 g)was extracted at room temperature for
3 days with small volume of diethyl ether (twice).The extracts
from flowers and leaves were dried in rotary evaporator
(Bu¨chi R-3000) under vacuum at 30∘C to give the following
extracts: diethyl ether extracts from flowers (DEF) and leaves
(DEL) and methanol extracts from flowers (MEF) and leaves
(MEL).
2.3.Ultraviolet-Visible (UV-Vis) Analysis. UV-Vis spectrawere
measured in ethanol using a Shimadzu UV-Vis 160 A spec-
trophotometer in the range 200–800 nm to detect chro-
mophoric systems with pharmacological potential.
2.4. Preliminary Screening to Select
a Promising Bioactive Extract
2.4.1. Effects of Plant Extracts on Bacterial Growth. Overnight
cultures of P. aeruginosa ATCC 27853 and Staphylococcus
aureus ATCC 6538 P were diluted to reach 2.5 × 106 CFU/mL
in Luria-Bertani (LB) and Mueller Hinton medium, respec-
tively. The diluted culture (190 𝜇L) was placed in each of
the 96 wells of a microtitre polystyrene plate. Solutions
containing 0.1mg/mL of extracts in DMSO–H
2
O (50 : 50)
were prepared separately and 10 𝜇L of each was pipetted to
the plastic microtitre plate wells individually (8 replicates).
Control wells (8 replicates) contained the diluted culture
(190 𝜇L) and 10 𝜇L of a solution of DMSO–H
2
O (50 : 50) in
which the final concentration of DMSO was 2.5%. Medium
control was prepared using sterile LB (or MH). Bacteria were
cultured in LB (or MH) medium at 37∘C and growth was
detected as turbidity (600 nm or 560 nm) using a microtitre
plate reader (Power Wave XS2, Biotek, VT, USA) and by
direct counting of CFU/mL determined by plating 0.1mL of
the inoculation onto LB agar (pH 6.0).Themaximum level of
DMSO to which the cells were exposed was 2.5%.
2.4.2. Antibiofilm Effects. For biofilm quantification, amicro-
method based on a protocol previously reported was emplo-
yed [23]. Biofilms formed after 24 h incubation of bacterial
cultures prepared as described in the previous paragraph
were stained with 20 𝜇L of an aqueous solution of crystal
violet (0.1%, w/v) for 20min. After washing with water, the
liquid was discarded from the wells and the material that
remained fixed to the polystyrene (containing biofilm) was
washedwith PBS (thrice). Crystal violet bound to biofilmwas
removed from each well employing 200𝜇L absolute ethanol
during 30min at 37∘C with shaking. Absorbance (540 nm)
of ethanol solutions of crystal violet was determined using
a microtitre plate reader (Power Wave XS2, Biotek, VT,
USA). Azithromycin (5 𝜇g/mL), a known quorum sensing
inhibitor, was incorporated in the bioassay as a control in
the same experimental conditions employed to evaluate the
compounds [24].
2.5. GC-EIMS and Isolation of Main Compound from a Bioac-
tive Extract. On the basis of antibacterial and antibiofilm
properties an extract among sixteen was selected and ana-
lyzed by gas chromatography techniques. GC-EIMS was
carried out using a Thermo Electron Trace Ultra cou-
ple with split-split less injector and Polaris Q instrument
(Thermo Scientific, TX, USA) ion trap mass spectrometer
equipped with a DB-5 capillary column (30m × 0.25mm,
film thickness 0.25 𝜇m). The initial temperature of the col-
umn was 60∘C during 0min. A temperature programming
was applied from 60∘C to 246∘C at a rate flow of 3∘C/min
and finally 280∘C for 15min. Carrier gas was helium (flow
Evidence-Based Complementary and Alternative Medicine 3
1mL/min). Split injection mode is 1/10. The identification of
volatile components was based on computer matching with
the NIST08 GC/MS library and by comparison of the mass
spectra, retention times (RT), and Kovats retention indexes
(RI) with those reported in the literature [25].
2.6. Chromatography Techniques. Diethyl ether extract from
leaves of M. dissecta (DEL, 1 g) were fractionated on sil-
ica gel (70–230Mesh, 1 : 50 w/w) column chromatography
employing petroleum ether and increasing amounts of EtOAc
(0–100%) and finally MeOH as mobile phase. The fourteen
fractions were monitored by TLC on aluminium-precoated
silica gel plates (Merck, Kieselgel 60 F
254
). The spots on the
plates were visualised under UV light, and the plates were
then sprayed with Godin reagent.
Fraction 4 isolated from DEL with a yield of 7.18%
(according to Section 3) was submitted to GC-EIMS analysis
and the main volatile compounds were determined. Then,
this fraction was rechromatographed with more silica gel
ratio (1 : 100, w/w) to give a known sesquiterpenewhoseNMR
and EIMS spectra were measured.
2.7. Antibacterial and Antibiofilm Activities of M. dissecta
Fractions. The bacterium screened was a biofilm pheno-
typic variant of Pseudomonas aeruginosa ATCC 27853, and
the medium and techniques employed were previously
described.
2.8. Antielastase 𝛽 Activity of M. dissecta Fractions. Elas-
tolytic activity was determined using a modification of the
method previously described [26]. The substrate of the
enzyme 𝛽-elastase, elastin Congo red (100 𝜇L) (Sigma), was
dissolved in Tris-HCl (pH 8.0) at a concentration of 5mg/mL
and then it was mixed with 100 𝜇L of cell-free culture
supernatant obtained from P. aeruginosa ATCC 27853 grown
during 24 h, in LB media containing 5 𝜇g/mL of fractions,
respectively. The reaction mixture (200𝜇L) was incubated at
37∘C for 24 h and centrifuged at 13,000 rpm for 10min. The
absorbance (495 nm) of the supernatant is a measure of the
enzyme activity.
2.9. Autoinducer (AHL) Quantification. The interruption of
bacterial cell-to-cell communication was deduced by autoin-
ducer (AHL) quantification, using 𝛽-galactosidase activity
assay. P. aeruginosa qsc 119 (reporter strain) is a mutant
donated by Dr. Greenberg that cannot produce its own
AHL (QS signal molecules). The reporter strain responds,
by producing 𝛽-galactosidase, to exogenous active signal
molecules generated by wild-type P. aeruginosa strains. P.
aeruginosa qsc 119 was constructed using a chromosomal
promoter under the control of AHLs linked to lacZ. In
consequence, 𝛽-galactosidase activity is under QS-control
and in direct relationship with the AHL activity [27].
An overnight culture of the reporter strain grown at
37∘C in LB was diluted ten times in the same medium,
reaching values of absorbance of 0.26 at OD
560 nm. A 100 𝜇L
portion of this suspension was mixed, in each microplate
well, with 100 𝜇L cell-free culture supernatant obtained from
P. aeruginosa ATCC 27853 cultured in LB media containing
100 𝜇g/mL of fractions, during 24 h. Azithromycin, known to
interfere with the QS process, was used at 5 𝜇g/mL, concen-
tration unable to affect the bacterial growth, as QS positive
control under the same conditions as fractions [23]. Control
wells (8 replicates) contained cell-free culture supernatant
(100 𝜇L) obtained from P. aeruginosa ATCC 27853 cultured
in LB media (190 𝜇L) plus 10 𝜇L of DMSO–H
2
O (50 : 50). 𝛽-
galactosidase activity was measured spectrophotometrically
by Miller test [28].
2.10. Statistical Analysis. Differences between means were
evaluated by analysis of variance (ANOVA). The Tukey test
was used for all pair-wise multiple comparisons of groups.
In all statistical analysis 𝑃 values > 0.05 were not considered
significant. Statistix 10 data analysis software for researches
(2013) was used.
3. Results and Discussion
3.1. UV Absorptions and Yields of Convolvulaceae Extracts.
All extracts showed a strong UV absorption (298–380 nm),
a typical feature of the occurrence of aromatic compounds.
These results are in agreement with the Convolvulaceae
chemistry as it has alreadymentioned, since thesemetabolites
are well known for their biological and pharmacological
potential. It is important to note that theMeOHextracts (ME)
exhibited the highest extraction yields (1.43–3.11%) reaching
3.11% in the ME of I. nil leaves (Table 1).
3.2. Antibacterial and Antibiofilm Activities of Convolvulaceae
Extracts. The diethyl ether extracts (DE) were more active
than methanol ones against P. aeruginosa growth as shown
in Table 1. The antibacterial activity could be due to the
presence of lipophilic compounds with lower polarity than
cholesterol (according to TLC profile). This fact suggests
that their principal targets are cell membranes and their
toxicity would be caused by loss of chemiosmotic control
as previously reported [29]. In relation to cell growth of S.
aureus, the in vitro results demonstrated that both extracts
are slightly active (Table 1).
Nevertheless, the addition of small amounts of MeOH
extracts into P. aeruginosa cultures produced a lower biofilm-
biomass than those of EE, except forM. dissectaDEL (diethyl
ether extract from leaves) which only allowed a 20% biofilm
formation (Table 1). In addition, this effect was correlated
with an important inhibition of bacterial growth. S. aureus
biofilm-biomass was also strongly reduced by all extracts
(71–100%), and these effects were not growth dependent. M.
dissecta MEF (MeOH extract from flowers) gave the best
biofilm inhibition (100%).
3.3. Selection of a Promising Extract for Bacterial Biofilm Con-
trol. M. dissectaDEL, which reduced P. aeruginosa biofilm by
80%, was selected among sixteen extracts to continue studies.
As it is unusual for natural products to be more active against
Gramnegative than positive bacteria [30], it is very important
to find active compounds against pathogenic P. aeruginosa,
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which is a major cause of infection in immune-compromised
patients. Indeed, these bacteria can cause serious infections
in patients who have received massive antibiotic therapy,
suffered severe burns, contracted HIV, or have a genetic
disease like cystic fibrosis [31].
M. dissecta has been employed traditionally as a condi-
ment, medicine, and ornament by an array of cultures. In
Argentina, roots of M. dissecta var. edentata are still used as
food by a few indigenous groups [16].
3.4. GC-EIMS Profile of M. dissecta Diethyl Ether Extract.
GC-EIMS analysis of M. dissecta DEL has led to the identi-
fication of nine plant volatile compounds (Table 2) such as
germacrene D (25.56%), 𝛽-caryophyllene (13.47%), spathu-
lenol (6.27%), 𝛽-elemene (4.70%), and 𝛿-elemene (2.65%)
(sesquiterpenes), while benzyl alcohol (11.17%), benzoic acid
(3.36%), and long-chain saturated fatty acids (17.28%) were
also determined. Thus, M. dissecta is a promising source
of sesquiterpenes and aromatic compounds with important
bioactivities.
3.5. Fractionation of M. dissecta Diethyl Ether Extract and
Bioactivities. DEL fractionation yielded fourteen fractions
of increasing polarity, and their comparative effects on
P. aeruginosa growth, biofilm production, and 𝛽-elastase
activity (%) were investigated here. As shown in Figure 1,
fractions 1–4 and 6 inhibit biofilm formation; particularly
fraction 4 eluted with petroleum ether-ethyl acetate 95 : 5
displayed the highest P. aeruginosa biofilm inhibition (55%).
Growth and elastolytic activity were inhibited by 31% and
27%, respectively. Coherently, the specific biofilm produced,
that is, the amount of biofilm that each bacterium forms
[10] calculated as the relation between the biofilm developed
(OD
540 nm) and bacterial growth (OD600 nm), was lower than
control (0.6537).
It is remarkable that fractions 5 and 7–14 showed a
strong increase of biofilm formation after 24 h of incuba-
tion, although the P. aeruginosa growth was not notably
inhibited as most stressors would. This composition-specific
behavior is consistentwith previous publications that demon-
strated that small chemical changes exert opposite effects
(inhibition-stimulation) [8, 10]. According to our previous
results [7, 32], this important stimulant effect could be
exploited to obtain a higher biofilm-biomass of polycyclic
aromatic hydrocarbon degrading Pseudomonas that would
improve strategies for optimizing the carcinogenic substances
bioremediation process.
In addition, the elastolytic activity of P. aeruginosa was
significantly reduced by all fractions compared to control
(13%–28%, 𝑃 < 0.05).
3.6. Antiquorum Sensing Mode of Action of M. dissecta Frac-
tions. All assayed fractions produced a notable decrease of
the P. aeruginosa autoinducer biosynthesis (63–75%). Par-
ticularly, fraction 4 showed an AHL activity reduction of
72% (Figure 2). The observed effects are correlated with
the biofilm formation and elastase activity decrease except
for fractions 5 and 7–14 that produced more biofilm than
C
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Figure 1: Effects of fractions 1–14 from Merremia dissecta on
Pseudomonas aeruginosa growth, biofilm production, and elastase
activity. Azi: azithromycin, C: Pseudomonas aeruginosa ATCC
27853, and 1–14: fractions of M. dissecta diethyl ether extract. The
error bars indicate standard deviation (𝑛 = 8). All experiments
showed significant differences with the control (𝑃 < 0.05).
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Figure 2: Quantification of N-acyl homoserine lactones signals
by 𝛽-galactosidase activity. Azi: azithromycin supernatant, C: P.
aeruginosa ATCC 27853 supernatant, and 1–14: fractions of M.
dissecta diethyl ether extract (supernatants). The error bars indicate
standard deviation (𝑛 = 8). All experiments showed significant
differences with the control supernatant (𝑃 < 0.05).
control (Figure 1). This lack of correspondence could be due
to another mechanism involved in biofilm formation.
It is very important to find plant natural products
that decrease AHL production, since AHLs are signals uti-
lized by Gram negative pathogenic bacteria to enable host
colonization through AHL-mediated inhibition of induced
inflammation via innate immune receptor mechanisms [33].
These signalling molecules inhibit lymphocyte proliferation
and tumour necrosis factor-𝛼 production.They also decrease
interleukin-12 production in lipopolysaccharide-stimulated
macrophages [34].
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Table 2: Volatile metabolites ofM. dissecta diethyl ether extract.
RTa (min) RIb Compounds Structure MWc
Main mass
fragmentation
peaks (𝑚/𝑧)
%
8.79 1036 Benzyl alcohol
HO
108
108 (M+∙), 107,
91, 79 (100%),
63 and 51
11.17
14.49 1150 Benzoic acid
COOH
122
122 (M+∙), 105
(100%), 77 and
51
3.36
20.80 1377 𝛿-Elemene 204
204 (M+∙), 189,
175, 161, 148,
136, 121 (100%),
105, 93, 77, 67
and 53
2.65
23.16 1398 𝛽-Elemene 204 189, 147, 107, 81(100%) and 68 4.70
24.45 1494 𝛽-Caryophyllene 204
204 (M+∙), 189,
161, 133, 105
and 93 (100%)
13.47
27.6 1515 Germacrene D 204
204 (M+∙), 161
(100%), 105, 79
and 55
25.56
31.05 1536 Spathulenol
OH
220
220 (M+∙), 205,
187, 159, 131,
119, 91 (100%),
79 and 55
6.27
38.9 Not identified 5.83
45.6 1869 Pentadecanoicacid HOOC 242
242 (M+∙), 199,
143, 129, 115, 87,
73 (100%), and
60
13.52
45.65 2167 Stearic acid HOOC 284
284 (M+∙), 265,
241, 185, 143,
129, 115, 97, 83,
73 (94%) and
57
3.76
aRT: retention time. bRI: Kovats retention indexes. cMW: molecular weight.
Evidence-Based Complementary and Alternative Medicine 7
T: + c Full ms [ 40,00–400,00]
91
77
119
79 105
43
117
15951 14765 131
11593 20367 145 187103 162 20212153 8150 149135 20585 95 22016358 17769 201 241 350317 389293253 338 380223 299 368271 284
1
HHO
15
9
7
H
14
5
11
12
2
3
4
68
10
13
60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 38040 400
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
la
tiv
e a
bu
nd
an
ce
Figure 3: EIMS profile of fraction 4 (+ spathulenol) and the assignments of the main mass fragmentation peaks. MS [m/z]: 220 [M∙+],
205 [M–CH
3
]+, 203 [M–OH]+, 202 [M–H
2
O]∙+, 187 [M–CH
3
–H
2
O]+, 177 [M–CH
3
–C=O]+ or [M–CH
3
–CH
2
=CH
2
]+, 163 [C
12
H
19
]+, 159
[C
12
H
15
]+, 147 [C
11
H
15
]+, 145 [C
11
H
13
]+, 119 [C
9
H
11
]+, 117 [C
9
H
9
]+, 105 [C
8
H
9
]+, 91 [C
7
H
7
]+ (100%), 77 [C
6
H
5
]+, 67 [C
5
H
7
]+, 65 [C
5
H
5
]+, 51
[C
4
H
3
]+, and 43 [C
3
H
7
]+.
3.7. Chemical Composition of the Bioactive Fraction 4. Spa-
thulenol was found in fraction 4 by GC-EIMS and NMR
analysis. Indeed, the NMR data of fraction 4 were identical
to those previously reported for (+) spathulenol [35], and
its EIMS profiling and the assignments of fragment ions are
shown here (Figure 3). Hence, these results lead us to suppose
that the antipathogenic effects exerted by fraction 4 can be
attributed to the occurrence of (+) spathulenol.
In addition, the antibacterial and antipathogenic proper-
ties of stereoisomer (−) ent-spathulenol isolated from Porella
species were previously demonstrated by Gilabert et al. [8].
However, it is important to note that (+) spathulenol, isolated
from leaves of the vascular plant M. dissecta, showed a
better anti-𝛽-galactosidase activity than (−) isomer found in
liverworts.
4. Conclusions
The bioguided study of the subtropical Convolvulaceae
species assayed provides evidence of the occurrence of
antipathogenic natural products active against Gram positive
and negative bacteria. Particularly, eukaryotic metabolites
such as (+) spathulenol from the ethnomedicinal plant M.
dissecta are able to interfere with the Pseudomonas aeruginosa
QS system by a strong decrease of the AHL biosynthesis
(72%) which attenuates virulence factor expression.
The biofilm matrix is a key therapeutic target, and our
findings suggest that the signalling pathway interruption
by natural products of M. dissecta could be exploited as
a good strategy for the development of new and effective
antipathogenic drugs.
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